Literature DB >> 7497590

Morphonuclear characterization of drug resistance by means of digital cell-image analysis: an in vitro assessment.

O Pauwels1, R Kiss.   

Abstract

The prediction of tumor resistance to antineoplastic drugs remains an important challenge in cancer chemotherapy. Several methods have been proposed in this connection, but they present a number of problems such as clinical relevance and applicability. In the present work we put forward an original methodology to assess the drug sensitivity of cancer cells. For this purpose we submitted chemosensitive and chemoresistant cell lines to different anticancer drugs and monitored the cell growth and the drug-induced morphonuclear effects by means of digital cell-image analysis of Feulgen-stained nuclei. The results showed that drug-induced effects at the morphonuclear level correlated statistically with the effects produced at the cell proliferation level. For example, the mean nuclear size value increased as a function of the drugs' efficiency recorded at the cell proliferation level. In the same way, the frequency of large dense chromatin clumps also increased in accordance with the drugs' efficiency. The present work thus demonstrates that digital cell-image analysis can be applied to monitor the efficiency of chemotherapeutic treatment carried out on cell lines in vitro. The present methodology could possibly be used on solid tumors, from which biological material can be obtained serially by means of fine-needle aspiration. As evidence of this, the present methodology can also be applied to hematological cancers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497590     DOI: 10.1007/bf00685647

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  41 in total

1.  Mechanism of inhibition of cell proliferation by Vinca alkaloids.

Authors:  M A Jordan; D Thrower; L Wilson
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

2.  Estrogen receptor characterization in a transplantable mouse mammary tumor.

Authors:  C Watson; D Medina; J H Clark
Journal:  Cancer Res       Date:  1977-09       Impact factor: 12.701

3.  Established cell line of urinary bladder carcinoma (T24) containing tumour-specific antigen.

Authors:  J Bubeník; M Baresová; V Viklický; J Jakoubková; H Sainerová; J Donner
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

4.  Morphometric, densitometric and flow cytometric criteria for the automated classification of thyroid lesions.

Authors:  O Ferrer-Roca; E Ballester-Guardia; J A Martin-Rodriguez
Journal:  Anal Quant Cytol Histol       Date:  1990-02       Impact factor: 0.302

Review 5.  Clinical significance of P-glycoprotein in multidrug resistance malignancies.

Authors:  R J Arceci
Journal:  Blood       Date:  1993-05-01       Impact factor: 22.113

6.  Expression of P-glycoprotein in relation to clinical manifestation, treatment and prognosis of adrenocortical cancer.

Authors:  H R Haak; A P van Seters; A J Moolenaar; G J Fleuren
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

7.  Computer-assisted microscope analysis of morphonuclear modifications induced by anticancer antimetabolites in cell lines cultured in vitro.

Authors:  O Pauwels; R Kiss; G Atassi
Journal:  Anticancer Drugs       Date:  1994-04       Impact factor: 2.248

8.  Digital cell image analysis of verapamil-induced effects in chemosensitive and chemoresistant neoplastic cell lines.

Authors:  C Etiévant; O Pauwels; R Kiss
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

Review 9.  Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokinetics.

Authors:  R T Dorr
Journal:  Semin Oncol       Date:  1992-04       Impact factor: 4.929

10.  Comparative study of multidrug resistance evaluated by means of the quantitative immunohistochemical detection of P-glycoprotein and the functional release of rhodamine 123.

Authors:  J P Delville; O Pradier; O Pauwels; A Van Onderbergen; R Kiss; W Feremans; P Capel
Journal:  Am J Hematol       Date:  1995-07       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.